Sumampong, Natividad B.
HRN: 24-08-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CLARITHROMYCIN 500MG (CAP)
11/17/2023
11/24/2023
PO
500mg
BID
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes